View Older Stories View More Recent Stories

Mar 31, 2025 08:45AM Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
Mar 31, 2025 08:00AM Construct Capital Closes $300 Million Fund III to Transform Foundational Industries
Mar 28, 2025 04:14PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 26, 2025 06:44AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
Mar 25, 2025 12:12PM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
Mar 25, 2025 09:01AM Illumina (ILMN) Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Mar 25, 2025 09:00AM Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Mar 21, 2025 09:00AM Second Front Systems Appoints Drew Hoffman as President and Chief Legal Officer
Mar 20, 2025 07:55PM Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Mar 20, 2025 04:01PM Senti Bio Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Pipeline and Corporate Highlights
Mar 20, 2025 06:45AM NeueHealth Reports Fourth Quarter and Full Year 2024 Results
Mar 18, 2025 05:04PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 10, 2025 07:01PM Form SCHEDULE 13D/A Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
Mar 6, 2025 08:00AM Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor
Mar 4, 2025 08:00AM Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board
Mar 4, 2025 12:45AM Renata Jungo Brüngger and Lila Tretikov to be nominated to the Board of Directors at the forthcoming Annual General Meeting
Feb 26, 2025 09:05AM Raise Secures $63 Million to Transform the Payments and Loyalty Industry with Blockchain-Powered Gift Cards
Feb 26, 2025 09:00AM HEAVY.AI and Ookla Partner to Revolutionize Network Analytics with Unprecedented Speed and Scale
Feb 20, 2025 07:09PM Form SCHEDULE 13D/A CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Feb 20, 2025 07:00AM NODAR and Leopard Imaging Announce Strategic Partnership to Showcase Advanced 3D Vision Technology at NVIDIA GTC 2025
Feb 20, 2025 05:00AM Smartcar Partners with BMW Group Europe to Deliver Enhanced Connected Mobility
Feb 18, 2025 09:00AM triValence Appoints Will Byington as Chief Executive Officer
Feb 18, 2025 09:00AM Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection
Feb 14, 2025 03:57PM Form SCHEDULE 13G/A Tuya Inc. Filed by: New Enterprise Associates 14, L.P.
Feb 12, 2025 07:00AM Abcuro Announces $200 Million Series C Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis
Jan 22, 2025 09:00AM NEA Promotes Hunter Worland and Mustafa Neemuchwala to Principal
Jan 21, 2025 11:30AM HEAVY.AI Announces Availability of Analytics Platform Accelerated by NVIDIA Grace Hopper Superchip
Jan 12, 2025 08:00PM Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs
Jan 9, 2025 08:00AM Aetion Appoints CEO and New Executive Chair of the Board
Jan 7, 2025 06:58PM Form SCHEDULE 13D/A NEXTNAV INC. Filed by: New Enterprise Associates 14, L.P.
Jan 7, 2025 08:00AM FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care
Jan 6, 2025 09:00AM Senti Biosciences (SNTI) Announces Additional $11.5M of Financing
Jan 6, 2025 09:00AM Senti Bio Announces Additional $11.5 Million of Financing
Jan 6, 2025 06:30AM Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles
Jan 6, 2025 06:30AM Novo Holdings Participates in €90 Million Series A Financing Round for Orbis Medicines to Support Development of Oral Macrocycle Drugs
Jan 3, 2025 11:15AM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MoneyLion Inc. (NYSE - ML), Marinus Pharmaceuticals, Inc. (Nasdaq - MRNS), Better Choice Inc. (NYSE American -
Jan 2, 2025 06:11PM SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating NeueHealth, Inc. Buyout
Dec 27, 2024 01:13PM SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of NeueHealth, Inc. (NEUE)
Dec 26, 2024 03:09PM Form SCHEDULE 13D/A NeueHealth, Inc. Filed by: New Enterprise Associates 17, L.P.
Dec 24, 2024 05:56AM Wall Street ends higher as Santa rally begins
Dec 23, 2024 05:53PM NeueHealth to Be Taken Private by NEA and Consortium of Investors
Dec 23, 2024 04:30PM Form SCHEDULE 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Dec 19, 2024 08:07AM Marker Therapeutics (MRKR) Announces $16.1 Million Private Placement
Dec 19, 2024 08:06AM Marker Therapeutics Announces $16.1 Million Private Placement
Dec 16, 2024 02:30AM Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million
Dec 4, 2024 07:08PM Form SC 13D/A Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
Dec 2, 2024 07:11AM Senti Biosciences (SNTI) Announces Oversubscribed $37.6 Million Private Placement Equity Financing
Dec 2, 2024 07:10AM Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity Financing
Nov 26, 2024 07:00AM Brenig Therapeutics Announces the Initiation of First-in-Human Clinical Trial of BT-267, a Best-in-Class LRRK2 Inhibitor for Parkinson's Disease
Nov 19, 2024 08:00AM SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension
View More Recent Stories View Older Stories